Esra Ozhamam

Esra Ozhamam

Auto-generated profile, based on publicly available information

Esra Ozhamam

Department of Pathology, Ankara Bilkent City Hospital, Ankara, Turkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in The Journal of International Advanced Otology
Verified
Journal Article
Open access
IGİsMail Güler
İsMail Güler
IKİhSan Kuzucu
İhSan Kuzucu
DBDeniz Baklaci
Deniz Baklaci
RKRauf Oğuzhan Kum
Rauf Oğuzhan Kum
EUEsra Özhamam Uçaryılmaz
Esra Özhamam Uçaryılmaz
MÖMüge Özcan
Müge Özcan
OBJECTIVES: The aim of this study was to assess whether nivolumab is ototoxic in rats and whether this ototoxicity is dose-dependent. MATERIALS and METHODS: Twelve rats were divided into two groups: Group 1 (control group, 6 rats, 12 ears) received intraperitoneal saline for 14 days. Group 2 (study group, 6 rats, 12 ears) and received two doses of 3 mg/kg intraperitoneal nivolumab within 14 days. Auditory brainstem responses (ABRs) were performed preoperatively and 4 and 8 weeks postoperatively. We compared between the groups, morphologic appearance of spiral ganglion cells and organ of Corti and density of spiral ganglion cells (measured with conventional light microscope connected to a personal computer). RESULTS: In our control group, both spiral ganglion and organ of corti had a normal morphological appearance. In our study group, spiral ganglion cells had a normal morphological appearance. However, some sections showed possibly mild degenerative changes in the organ of corti. Of 12 samples in the study group, four had a significant loss of density of spiral ganglion cells compared to the control group. The baseline ABR thresholds did not significantly differ between the groups (p=0.713). There was no statistically significant difference between the groups regarding ABR thresholds at week 4 (p=0.347). However, a statistically significant difference was observed in the ABR thresholds at week 8 (p=0.045). CONCLUSION: The results of our study showed that nivolumab treatment has ototoxic effects. Based on our results, we recommend monitoring the changes in the hearing ability of chemotherapy patients. Cite this article as: Güler İ, Kuzucu İ, Baklacı D, Kum RO, Özhamam Uçaryılmaz E, Özcan M. Evaluation of Nivolumab for Ototoxic Effects: An Animal Study in Rats. J Int Adv Otol 2020; 16(2): 218-21.

26 December 2019 in International Wound Journal
Verified
Journal Article
Closed access
PDF file
PUPinar Incel Uysal
Pinar Incel Uysal
NANeslihan Akdogan
Neslihan Akdogan
OBOnder Bozdogan
Onder Bozdogan
EOEsra Ozhamam
Esra Ozhamam
SCSeray Cakmak
Seray Cakmak
BYBasak Yalcin
Basak Yalcin

3 July 2026 in Medicine
Verified
Journal Article
Open access
ENEsra Kiratli Nalbant
Esra Kiratli Nalbant
SASezin Unlu Acikel
Sezin Unlu Acikel
EOEsra Ucaryilmaz Ozhamam
Esra Ucaryilmaz Ozhamam
YHYildiz Hayran
Yildiz Hayran
Pityriasis lichenoides (PL) is a rare inflammatory skin disorder of unknown etiology, comprising a spectrum of 2 clinical variants: pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta. Due to its rarity, data on its clinical and histopathological features (particularly age-related differences) remain limited. This retrospective, cross-sectional study included patients diagnosed with PL between January 2019 and January 2024 at a tertiary dermatology clinic. Demographic data, clinical presentation, histopathological subtype, treatment modalities, and disease outcomes were collected. Patients were stratified into pediatric (<18 years) and adult (≥18 years) groups for comparative analysis. A total of 41 patients were evaluated (29 adults, 12 children). The majority were diagnosed with pityriasis lichenoides chronica (80.5%). Erythema, scaling, and papules/plaques were the most common dermatological findings. Papular lesions were significantly more frequent in adults ( P = .024), while hypopigmentation was observed exclusively in children ( P = .024). No significant differences were noted between the 2 groups in terms of lesion distribution, histopathological subtype, or disease severity. During follow-up, 23 patients (56.1%) were lost to follow-up. Among the remaining patients, complete or partial remission was achieved in 14 patients, while 2 patients had persistent disease and 2 experienced relapse, with no significant outcome differences between pediatric and adult groups. This study highlights age-related differences in the clinical presentation of PL, particularly the exclusive presence of hypopigmentation in children and papular predominance in adults. Despite these clinical distinctions, histopathological patterns and overall disease severity did not significantly differ between age groups. Larger prospective studies are needed to further explore age-related variations and treatment responses in PL.

21 October 2019 in Turkish Journal of Hematology
Verified
Journal Article
Open access
MOMufide Okay Ozgeyik
Mufide Okay Ozgeyik
TATuncay Aslan
Tuncay Aslan
EÖEvren Özdemir
Evren Özdemir
AÜAysegul Üner
Aysegul Üner
ASArzu Sağlam
Arzu Sağlam
YBYahya Buyukasik
Yahya Buyukasik
Objective: Chronic antigenic stimulation is frequently blamed in the pathogenesis of extranodal marginal zone lymphomas including splenic marginal zone lymphoma (SMZL). Chronic hepatitis C is frequently observed in SMZL patients in some geographical regions. However, these reports are largely from North America and Europe, and data from other countries are insufficient. In this multicenter study we aimed to identify the clinical characteristics of SMZL patients in Turkey, including viral hepatitis status and treatment details. Materials and Methods: Data were gathered from participating centers from different regions of Turkey using IBM SPSS Statistics 23 for Windows. Hepatitis B virus surface antigen (HBsAg), anti-HBs antibody, anti-HB core antigen antibody (anti-HBcAg), HB viral load, anti-hepatitis C virus (HCV) antibody, HCV viral load results were analyzed. Results: One hundred and four patients were reported. Hepatitis C virus positivity was observed in only one patient. However, hepatitis B virus surface antigen (HBsAg) positivity was observed in 11.2% and HBsAg and/or anti-HB core antigen antibody (anti-HBcAg) positivities were seen in 34.2% of the patients. The median age was 60 years (range=35-87). Median follow-up duration was 21.2 months (range=00.2-212; 23.2 months for surviving patients). Median overall survival was not reached. Estimated 3-year and 10-year survival rates were 84.8% and 68.9%, respectively. Older age, no splenectomy during follow-up, platelet count of <90x10(3)/mu L, lower albumin, higher lactate dehydrogenase, higher beta(2)-microglobulin, and HBsAg positivity were associated with increased risk of death. Only albumin remained significant in multivariable analysis. Conclusion: These results indicate that hepatitis B virus may be a possible risk factor for SMZL in our population. It may also be an indirect prognostic factor.

22 May 2020 in Journal of Turkish Spinal Surgery
Verified
Journal Article
Closed access
EIEgemen Isitan
Egemen Isitan
EÖEsra Uçaryilmaz Özhamam
Esra Uçaryilmaz Özhamam
ABAydın Talat BAYDAR
Aydın Talat BAYDAR
SGServet Güreçci̇
Servet Güreçci̇
ÖUÖzhan Merzuk Uçkun
Özhan Merzuk Uçkun
ADAli Dalgiç
Ali Dalgiç

18 November 2024 in Turkish Journal of Hematology
Verified
Journal Article
Open access
MPMehmet Sezgin Pepeler
Mehmet Sezgin Pepeler
SDsimten dağdaş
simten dağdaş
EIEmel Isleyen
Emel Isleyen
GKGaye Katayıfçı
Gaye Katayıfçı
AKAydan Kılıçarslan
Aydan Kılıçarslan
GOgulsum ozet
gulsum ozet